Last Posted: Oct 03, 2019
- Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart Anne et al. BMJ open 2019 Sep 9(9) e029926 - Cancer Genetic Counseling and Testing in an Era of Rapid Change.
Hooker Gillian W et al. Journal of genetic counseling 2017 Dec 26(6) 1244-1253 - Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Pelttari L M et al. Clinical genetics 2018 93(3) 595-602 - Hereditary breast and ovarian cancer.
Barks Phyllis et al. JAAPA : official journal of the American Academy of Physician Assistants 2012 Mar 25(3) 63-5 - Managing hereditary breast cancer risk in women with and without ovarian cancer.
Peters Mary Linton et al. Gynecologic oncology 2017 146(1) 205-214 - Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.
Ndugga-Kabuye Mesaki K et al. Familial cancer 2019 Sep - Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Greenberg Samantha et al. Cancer medicine 2019 Sep - Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.
Fragoso-Ontiveros Veronica et al. PloS one 2019 14(9) e0222709 - Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.
Rashid Muhammad Usman et al. Hereditary cancer in clinical practice 2019 1727 - Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.
Manchanda R et al. BJOG : an international journal of obstetrics and gynaecology 2019 Sep
.png)
No hay comentarios:
Publicar un comentario